Skip to main content
KYMR filings

Corporate insider profile

Mark N Lampert Filing Activity

Latest reported as Corporate insider of Kymera Therapeutics, Inc. (KYMR).

Purchase filings
0
Reported companies
1
Net open-market value
-$173,665,077.00
Latest transaction
Jun 26, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 26, 2026Kymera Therapeutics, Inc. (KYMR)Corporate insiderSale1,630,658$106.50$173,665,077